Leverages AI to create disease-specific Digital Twins from clinical trial data, accelerating research in neurological diseases like Alzheimer’s.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Unlearn.AI leverages its proprietary DiGenesis™ platform which processes historical clinical trial datasets from thousands of patients to build the disease-specific machine learning models used to create Digital Twins and their corresponding virtual medical records. Digital Twin records are longitudinal and include demographic information, common lab tests, and endpoints and/or biomarkers that look identical to actual patient records in a clinical trial. The company’s initial focus is on neurological diseases, starting with Alzheimer’s Disease and Multiple Sclerosis.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Unlearn Management Team
Investors
8VC
DCVC
Insight Partners
Mubadala Capital
Radical Ventures
Unlearn Valuations & Financials
View real-time NPM data on Unlearn stock including daily Unlearn stock price estimates, valuation history, and historical share price information. Access Unlearn financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Unlearn pricing across six independent market signals. Looking for private company due diligence data sources on Unlearn? Get in touch to learn more.
Similar Companies
like Unlearn
Nomad Health
Healthcare & Life Sciences
Provides an AI platform that automates customer service interactions and resolves requests across channels to improve efficiency and support quality.
ReliefBand Technologies
Healthcare & Life Sciences
Builds neuromodulation wristbands to treat physical symptoms of nausea without pharmaceuticals.
Maximum Fidelity Surgical Simulations
Healthcare & Life Sciences
Engineers automated surgical simulation platforms to provide realistic physiological feedback during clinical training.
Curebase
Healthcare & Life Sciences
Enables decentralized clinical trials with all-in-one software, empowering patient choice and supporting virtual and traditional site operations.
Dacadoo
Healthcare & Life Sciences
Digital health platform using AI and behavioral science to improve wellness outcomes through personalized engagement and gamification.
Min Doktor
Healthcare & Life Sciences
Digital healthcare platform providing 24/7 online medical consultations, prescriptions and referrals through licensed healthcare professionals.
Proniras
Healthcare & Life Sciences
Develops novel small-molecule therapeutics for substance use and specialty CNS disorders targeting unmet medical needs.
CivicEye
Healthcare & Life Sciences
Delivers advanced cloud-based software that streamlines operations for law enforcement and public safety professionals.
Nurotron
Healthcare & Life Sciences
Develops and manufactures neurostimulation systems and cochlear implants to restore hearing for people with severe hearing loss.
FAQ
We have answers
Unlearn stock does not trade on public stock exchanges. Unlearn stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Unlearn stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Unlearn Stock does not trade on public stock exchanges. In order to sell Unlearn shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Unlearn does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Unlearn share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Unlearn stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Unlearn stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Unlearn stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Unlearn is a private company and has not had an IPO. There is currently no Unlearn IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Unlearn IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
